[Comparative study of molecular response of first-line and second-line nilotinib in patients with chronic-phase chronic myelogenous leukemia].
Zhonghua Xue Ye Xue Za Zhi
; 40(6): 522-525, 2019 06 14.
Article
en Zh
| MEDLINE
| ID: mdl-31340628
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Pirimidinas
/
Leucemia Mieloide de Fase Crónica
Idioma:
Zh
Revista:
Zhonghua Xue Ye Xue Za Zhi
Año:
2019
Tipo del documento:
Article